197 related articles for article (PubMed ID: 35433701)
1. Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15.
Yue L; Zhang R; Chen S; Duan G
Front Cell Dev Biol; 2022; 10():710708. PubMed ID: 35433701
[No Abstract] [Full Text] [Related]
2. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer.
Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R
J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518
[No Abstract] [Full Text] [Related]
3. Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma.
Chen D; Guo W; Yu H; Yang J
Transl Cancer Res; 2022 Sep; 11(9):3064-3079. PubMed ID: 36237271
[TBL] [Abstract][Full Text] [Related]
4. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and Predictive Value of m6A "Eraser" Related Gene Signature in Gastric Cancer.
Xu X; Zhou E; Zheng J; Zhang C; Zou Y; Lin J; Yu J
Front Oncol; 2021; 11():631803. PubMed ID: 33718213
[TBL] [Abstract][Full Text] [Related]
6. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
7. Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model.
Li J; Zuo Z; Lai S; Zheng Z; Liu B; Wei Y; Han T
J Gastrointest Oncol; 2021 Aug; 12(4):1384-1397. PubMed ID: 34532096
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
Wang JM; Li X; Yang P; Geng WB; Wang XY
BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer.
Jiang F; Chen X; Shen Y; Shen X
Front Genet; 2022; 13():891744. PubMed ID: 35928449
[No Abstract] [Full Text] [Related]
11. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
12. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer.
Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D
J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685
[TBL] [Abstract][Full Text] [Related]
13. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
Front Oncol; 2021; 11():726018. PubMed ID: 35299934
[TBL] [Abstract][Full Text] [Related]
14. Estimating the prognosis of esophageal squamous cell carcinoma based on The Cancer Genome Atlas (TCGA) of m6A methylation-associated genes.
Pu Y; Lu X; Yang X; Yang Y; Wang D; Li M; Guan W; Xu M
J Gastrointest Oncol; 2022 Feb; 13(1):1-12. PubMed ID: 35284129
[TBL] [Abstract][Full Text] [Related]
15. To Develop and Validate the Combination of RNA Methylation Regulators for the Prognosis of Patients with Gastric Cancer.
Zhang J; Piao HY; Wang Y; Meng XY; Yang D; Zhao Y; Zheng ZC
Onco Targets Ther; 2020; 13():10785-10795. PubMed ID: 33122917
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer.
Yu L; Wang L; Sun J; Zhou X; Hu Y; Hu L; He Y; Lin C; Chen J; Xu X; Dunlop MG; Theodoratou E; Ding K; Li X
Front Genet; 2023; 14():885930. PubMed ID: 36936424
[TBL] [Abstract][Full Text] [Related]
17. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
Zhao J; Lin X; Zhuang J; He F
Front Genet; 2021; 12():714697. PubMed ID: 34777460
[No Abstract] [Full Text] [Related]
18. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
20. RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer.
Mu LX; Shao YC; Wei L; Chen FF; Zhang JW
Front Genet; 2021; 12():650499. PubMed ID: 35095993
[No Abstract] [Full Text] [Related]
[Next] [New Search]
